Management-Consulting Experte in Life Sciences / Health Care

In explicite Management Consultancy: - Conceptual management of international consulting teams for various clients: restructuring and reorganization of departments (medical, drug safety management, post-marketing-surveillance, marketing, sales, business development, market access and health technology assessments (HTAS), quality assurance etc.), M&A, after-merger integration, business intelligence / market analytics. - Organizational optimization of central, international and decentralized national areas in medicine, sales, marketing, finance & controlling, licensing and asset scouting. - Project management to optimize portfolios in research & development / marketing & sales, project pipeline improvements, coupled with the optimization of R & D / medical functions in synthesis, preclinical and clinical studies of phases I to IIIb / IV and post marketing surveillance. - Implementation and management of national and international lifecycle optimization projects. - Development and implementation of strategies, concepts, key actions in strategic and operational implementation: medical, marketing and sales units (premarketing, launches, relaunch, medical performance, marketing performance, programs market access, customer loyalty and CME programs (congresses, symposia, evening events etc.) for medical specialists and physicians in various indication fields, optimization of resource allocation vs. trade-offs etc. - Market access analyzes and concepts, concerning the cooperation of the health care industry with health insurance funds, price studies, etc., nationally and internationally. - Creation or further development of profit and loss-relevant 5-10-year strategic plans or 1-5 year operational plans, for projects, products, business units / franchises, to optimize the national and international business performance of clients. - National / international investment / return assessments, break-even calculations, model developments for P & L evaluations of profit centers and business units, combined with national and international planning, resource allocations in functional areas, etc., and associated controlling programs. - Analyzes and projects for cooperation models (co-development, co-promotion, co-marketing) and improvement of licensing, acquisitions, contract management and transactions. - Planning and carrying out individual and group coaching of teams and executives of various functional areas with focus on strategies, concepts, SWOT, strategic key drivers, bottleneck analyzes, upside and downside management. - Strategic realignments: optimization of sales, market shares and profit - Opportunity and risk assessments: markets, projects, products, technologies - Change Management: mindset, Soft- & Hard Factors - Innovation management: strategic, operational and process optimization of R & D, marketing, medicine, sales, key account management; Including: Prioritization frames for total portfolio, franchise portfolio, individual assets - Cooperations in R & D, franchise portfolio, individual assets, cooperations and / or partnerships / co-models - Right-Sizing: Optimize the balance between resource allocation, sales and return / net operating cash flow - Customer Access / customer loyalty programs: strategies, concepts, key actions for co-operation with health insurances / rehabilitation and medical professionals, improvement of market and customer position, creation and optimization of CRM - Strategies and key actions on market access / health economics: studies and analyses / evaluations for strategies, price, cost-benefit and reimbursement aspects, optimization and design of chronicle programs / DMPs, etc. - Market assessments: studies, audits and analyses on markets, customers, target groups, technologies, competitors - Business partnering: investment return consulting, business plans, business transactions support, licensing / contracting to projects, products, franchises, company portfolios (R & D / M & S) and markets. In Executive Management: - Procuration for an International Group. - Member of the Board Groups "Central R&D-Steering Committee" and "Global Licensing, Merging & Acquisition". - Management of a "central team" of> 150 specialists (physicians, pharmacologists, economists etc.). - Managing the reporting lines of all national affiliates, in medical affaisrs, marketing and new producsts/licensing and acquisitions. - Co-Responsibility for decentralized units with> 1,500 employees (> 25 subsidiaries abroad,> 50 representations abroad). - Full responsibility for own divisional budget. - Co-responsibility for corporate sales in 4-digit million € and for the high 3-digit million € corporate operating result. - Strategic and operational responsibility for the innovation and market portfolio, and for the creation and implementation of compliance within the Group. - Revenue increase over 5 years: per year> 13% - Earnings increase over 5 years: per year> 15% - Successful reorganization and restructuring of the international central divisions "Medicine" and "Marketing" of the international group, as well as in various affiliates of the international group. - Successful Drug Risk Management of a global product with annual sales of € 850 million. - Launch of a global product with sales> 1 billion €, and other global successful product launches. - Successful restructuring and focusing on the overall R & D portfolio of the international pharmaceutical group. - Successful reorganization of Top-KOL-based international CME-program, centrally (international) and de-centrally (national at affilites). - Optimization of the Inlicensing and M & A process of the international pharmaceutical group. - Optimization of external exhibitions and participations in congresses and symposia.